Literature DB >> 12937232

Impaired expression of glycoproteins on resting and stimulated platelets in uraemic patients.

Valérie Moal1, Philippe Brunet, Laetitia Dou, Sophie Morange, José Sampol, Yvon Berland.   

Abstract

BACKGROUND: The increased bleeding tendency of chronic renal failure (CRF) patients has been attributed to platelet dysfunction. However, reports on various platelet functions in uraemic patients have been conflicting. The present study sought to analyse platelet function by examining their surface glycoproteins in well-identified populations of CRF patients.
METHODS: Three groups were studied: 22 chronic haemodialysis (HD) patients, 25 conservatively treated patients with CRF and 30 controls. Bleeding tendency was assessed by measuring bleeding time and by recording current haemorrhagic symptoms. We measured the fibrinogen receptor GPIIbIIIa, the von Willebrand receptor GPIb, and P-selectin levels on the platelet surface using flow cytometry.
RESULTS: Forty percent of CRF and 45% of HD patients had bleeding. The bleeding time was similar in the HD and CRF groups, but was longer in both groups than in controls. In resting platelets, GPIb expression was lower in CRF patients than in controls. In stimulated platelets (i) GPIb expression was higher in HD patients than in both controls and CRF patients; and (ii) GPIIbIIIa and P-selectin expression were lower in CRF and HD patients than in controls.
CONCLUSIONS: These findings indicate that uraemic platelets are hyporesponsive to stimulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937232     DOI: 10.1093/ndt/gfg185

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  21 in total

1.  Patient-specific antithrombotic strategies: lessons not yet learned from the renal insufficiency paradigm.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2005-06       Impact factor: 2.300

2.  Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials.

Authors:  Min Jun; Jicheng Lv; Vlado Perkovic; Meg J Jardine
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

Review 3.  [Thrombocytopathy and blood complications in uremia].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2006-04       Impact factor: 1.704

4.  Effects of Salivae Miltiorrhizae Liguspyragine Hydrochloride and Glucose Injection on the levels of main platelet thrombin receptors in chronic haemodialysis patients.

Authors:  Yan Li; Lin Shen; Rui Chen; Jing Li; Fu-rong Lu; You Qin; Jan-guo Liu
Journal:  Chin J Integr Med       Date:  2011-08-09       Impact factor: 1.978

5.  GPIbα reflects the development and progress of the patients with severe preeclampsia.

Authors:  Fu-Ju Wu; Ming-Yang Zheng; Lian-Lian Liu; Dan-Dan Wang; Xiao-Yan Ma
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 6.  Percutaneous coronary interventions and antiplatelet therapy in renal transplant recipients.

Authors:  Francesco Summaria; Maria Benedetta Giannico; Giovanni Paolo Talarico; Roberto Patrizi
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-12-16

7.  Evaluating safety of thrombolysis in chronic kidney disease patients presenting with pulmonary embolism using propensity score matching.

Authors:  Brijesh Patel; Naveen Sablani; Mahek Shah; Lohit Garg; Manyoo Agarwal; Sahil Agrawal; Susan Steigerwalt; Raman Dusaj
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

8.  Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro.

Authors:  Esther R van Bladel; Rosa L de Jager; Daisy Walter; Loes Cornelissen; Carlo A Gaillard; Leonie A Boven; Mark Roest; Rob Fijnheer
Journal:  BMC Nephrol       Date:  2012-09-28       Impact factor: 2.388

9.  Combined blockade of ADP receptors and PI3-kinase p110β fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation.

Authors:  Stefanie Krajewski; Julia Kurz; Tobias Geisler; Karlheinz Peter; Hans Peter Wendel; Andreas Straub
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

10.  Increased Prevalence of Glycoprotein IIb/IIIa Leu 33 Pro Polymorphism in End Stage Renal Disease Patients on Hemodialysis.

Authors:  Amein Al-Ali; Fahad Al-Muhanna; Samir Al-Mueilo; Emmanuel Larbi; Ali Al-Sultan; Abdullah Rubaish; Suad Al-Ateeq; Alhusain Al-Zaharani
Journal:  Int J Biomed Sci       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.